Nevena Grdović

Dr. Nevena Grdović

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
MMMirjana Mihailović
Mirjana Mihailović
SDSvetlana Dinić
Svetlana Dinić
JJJelena Arambasic Jovanovic
Jelena Arambasic Jovanovic
AUAleksandra Uskokovic
Aleksandra Uskokovic
NGNevena Grdović
Nevena Grdović
Melita VidakovicMelita Vidakovic
Melita Vidakovic
Diabetes is a complex metabolic disorder resulting either from insulin resistance or an impaired insulin secretion. Prolonged elevated blood glucose concentration, the key clinical sign of diabetes, initiates an enhancement of reactive oxygen species derived from glucose autoxidation and glycosylation of proteins. Consequently, chronic oxidative stress overwhelms cellular endogenous antioxidant defenses and leads to the acute and long-standing structural and functional changes of macromolecules resulting in impaired cellular functioning, cell death and organ dysfunction. The oxidative stress provoked chain of pathological events over time cause diabetic complications such as nephropathy, peripheral neuropathy, cardiomyopathy, retinopathy, hypertension, and liver disease. Under diabetic conditions, accompanying genome/epigenome and metabolite markers alterations may also affect glucose homeostasis, pancreatic β-cells, muscle, liver, and adipose tissue. By providing deeper genetic/epigenetic insight of direct or indirect dietary effects, nutrigenomics offers a promising opportunity to improve the quality of life of diabetic patients. Natural plant extracts, or their naturally occurring compounds, were shown to be very proficient in the prevention and treatment of different pathologies associated with oxidative stress including diabetes and its complications. Considering that food intake is one of the crucial components in diabetes’ prevalence, progression and complications, this review summarizes the effect of the major plant secondary metabolite and phytoconstituents on the antioxidant enzymes activity and gene expression under diabetic conditions.

16 January 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
JJJelena Arambasic Jovanovic
Jelena Arambasic Jovanovic
MMMirjana Mihailović
Mirjana Mihailović
AUAleksandra Uskokovic
Aleksandra Uskokovic
NGNevena Grdović
Nevena Grdović
SDSvetlana Dinić
Svetlana Dinić
Melita VidakovicMelita Vidakovic
Melita Vidakovic
Diabetes mellitus is a life-threatening multifactorial metabolic disorder characterized by high level of glucose in the blood. Diabetes and its chronic complications have a significant impact on human life, health systems, and countries’ economies. Currently, there are many commercial hypoglycemic drugs that are effective in controlling hyperglycemia but with several serious side-effects and without a sufficient capacity to significantly alter the course of diabetic complications. Over many centuries mushrooms and their bioactive compounds have been used in the treatment of diabetes mellitus, especially polysaccharides and terpenoids derived from various mushroom species. This review summarizes the effects of these main mushroom secondary metabolites on diabetes and underlying molecular mechanisms responsible for lowering blood glucose. In vivo and in vitro data revealed that treatment with mushroom polysaccharides displayed an anti-hyperglycemic effect by inhibiting glucose absorption efficacy, enhancing pancreatic β-cell mass, and increasing insulin-signaling pathways. Mushroom terpenoids act as inhibitors of α-glucosidase and as insulin sensitizers through activation of PPARγ in order to reduce hyperglycemia in animal models of diabetes. In conclusion, mushroom polysaccharides and terpenoids can effectively ameliorate hyperglycemia by various mechanisms and can be used as supportive candidates for prevention and control of diabetes in the future.

1 August 2013 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
SMSanja Lj Matić
Sanja Lj Matić
SSSnežana Stanić
Snežana Stanić
DBDesanka Bogojević
Desanka Bogojević
Melita VidakovicMelita Vidakovic
Melita Vidakovic
NGNevena Grdović
Nevena Grdović
MMMirjana Mihailović
Mirjana Mihailović

1 April 2011 in Food Chemistry
Verified
Journal Article
Closed access
AMAida Mujić
Aida Mujić
NGNevena Grdović
Nevena Grdović
IMIbrahim Mujić
Ibrahim Mujić
MMMirjana Mihailović
Mirjana Mihailović
JŽJelena Vladeta Živković
Jelena Vladeta Živković
Melita VidakovicMelita Vidakovic
Melita Vidakovic

12 October 2012 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
JJJelena Arambasic Jovanovic
Jelena Arambasic Jovanovic
MMMirjana Mihailović
Mirjana Mihailović
AUAleksandra Uskokovic
Aleksandra Uskokovic
SDSvetlana Dinić
Svetlana Dinić
NGNevena Grdović
Nevena Grdović
Melita VidakovicMelita Vidakovic
Melita Vidakovic

1 January 2016 in Proceedings of the Japan Academy, Series B
Verified
Journal Article
Open access
PDF file
SDSvetlana Dinić
Svetlana Dinić
NGNevena Grdović
Nevena Grdović
AUAleksandra Uskokovic
Aleksandra Uskokovic
MĐMiloš ĐORĐEVIĆ
Miloš ĐORĐEVIĆ
MMMirjana Mihailović
Mirjana Mihailović
Melita VidakovicMelita Vidakovic
Melita Vidakovic
Due to intrinsically low levels of antioxidant enzyme expression and activity, insulin producing pancreatic β-cells are particularly susceptible to free radical attack. In diabetes mellitus, which is accompanied by high levels of oxidative stress, this feature of β-cells significantly contributes to their damage and dysfunction. In light of the documented pro-survival effect of chemokine C-X-C Ligand 12 (CXCL12) on pancreatic β-cells, we examined its potential role in antioxidant protection. We report that CXCL12 overexpression enhanced the resistance of rat insulinoma (Rin-5F) and primary pancreatic islet cells to hydrogen peroxide (H2O2). CXCL12 lowered the levels of DNA damage and lipid peroxidation and preserved insulin expression. This effect was mediated through an increase in catalase (CAT) activity. By activating downstream p38, Akt and ERK kinases, CXCL12 facilitated Nrf2 nuclear translocation and enhanced its binding to the CAT gene promoter, inducing constitutive CAT expression and activity that was essential for protecting β-cells from H2O2.